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Currently, one of the most important tasks facing science and production is the creation of functional product 
technologies for use in different diets of the population in order to preserve and improve health, as well as re-
duce the risks and consequences of various diseases, including hereditary ones, such as phenylketonuria (PKU). 
The All-Russian Research Institute of Starch Products develops technologies for the production of low-protein 
starch-based products/semi-products enriched with functional ingredients and intended for therapeutic nutri-
tion of patients with PKU. As part of the pilot production, the production of these products is organized. Purpose 
of work:- to justify the possibility of using dry components of chicken eggs (melange, protein, yolk) to enrich 
low-protein starch products (noodles, vermichel, «spider») intended for feeding children over 3 years old with 
phenylketonuria;- evaluate organoleptic properties and efficiency of low-protein starch products enriched in hy-
pophenylalanine diet of patients with phenylketonuria older than 3 years.
FUNDING: The article was published as part of the research topic No. 0585–2019–0031-C-01 of the state as-assignment of the V. M. Gorbatov Federal 
Research Center for Food Systems of RAS and Research «Scientific justification and development of modern methods of dietary therapy for various 
diseases in children in a multidisciplinary hospital using specialized children’s foods» FSAU «National Medical Research Center for Child Health»
1. Introduction
In recent years, studies have been carried out confirming 
the possibility of using dry ingredients of chicken eggs (protein, 
yolk, melange) to enrich low-protein starch products [1,2,3]. An 
important factor determining the feasibility of using enriched 
starch products in the nutrition of children with phenylketon-
uria is the low content of protein and, accordingly, phenylala-
nine. It has been established that the inclusion of new ingredi-
ents in small quantities in the composition of dry semi-products 
allows them to be used in low-protein dietary therapeutic diets 
of patients with PKU, primarily in the nutrition of children.
Two fundamentally new technological techniques have been 
developed for introducing dry ingredients of chicken eggs into 
the starch base: the first is the moisture-thermal treatment of 
a mixture of corn starch and egg products on a roller dryer, the 
second is the mechanical mixing of the added ingredients and 
swellable corn starch.
It was found that the physicochemical properties (swelling, 
solubility, conditional viscosity) of products obtained using vari-
ous technological methods are close to each other.
A comparison of the two methods of producing new starch 
mixtures in combination with dry egg products has shown that 
it is preferable to use a mechanical mixing method because it is 
simpler and more economical.
2. Materials and methods
The main ingredients for the production of pasta were: corn 
starch (GOST 32159–2013) and extrusion corn starch of domes-
tic production «Extramil» (TU9187–001–18020121–2001).
To enrich pasta, dry egg yolk (GOST 30363–2013) and Ve-
toron Children’s Solution (TU9197–033–58693373–06 with 
changes 1, 2) were used.
According to the results of previous studies [4.5], it has been 
found that in the development of the formulation of low-protein 
products, all three components of chicken eggs can be used as a 
functional additive, but it is preferable to use dry yolk, which is 
more suitable in quality composition for baby food. Compared to 
egg melange and protein, the yolk has a higher energy value and 
the smallest amount of protein, and therefore phenylalanine. 
In  addition, it surpasses melange and protein in terms of or-
ganoleptic properties, since it has a pronounced taste and smell 
characteristic of a chicken egg.
Analysis of the chemical composition of new pasta showed 
that their protein content per 100 g of dry product is less than 
1.0%, fat 3.3–3.6%, ash up to 0.14%, carbohydrates no more 
than 88.0%, energy value ranges from 1614.1–1617.8 kJ (386.14–
387.04 kcal).
The results of the analytical evaluation confirmed that the 
ingredient composition of these products fully meets the re-
quirements for food products of this class (specialized low-pro-
tein products) used in the therapeutic and dietary nutrition of 
patients with phenylketonuria [6,7,8].
Clinical studies of the safety and effectiveness of these low-
protein pasta used for the preparation of low-protein dishes were 
carried out on the basis of the Advisory and Diagnostic Center of 
the Federal State Research Institute for Children’s Health of the 
Ministry of Health of the Russian Federation.
Evaluation of the effectiveness of the use of pasta of low-
protein starch enriched for dietary therapeutic nutrition for 
children over 3 years of age: Vermichel, Noodles, Spider was an 
incomparable, prospective, single-center, uncontrolled study.
Parents (legal representatives) were informed in detail about 
the goals and tasks of the work, followed by obtaining written in-
formed consent to participate in the study. Children who met the 
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inclusion criteria and had no contraindications to prescribing the 
above low-protein products were randomly selected for follow-up.
Inclusion criteria:
  Children of both sexes between the ages of 3 and 18 years 
with classical phenylketonuria confirmed at neonatal screen-
ing on a hypophenylalanine diet;
  having written consent of parents/legal representatives to 
participate in the study.
Exclusion criteria:
  acute infectious disease.
The study design is shown in Figure 1.
Under supervisionthere were 10 patients with phenylke-
tonuria, of which 4 boys and 6 girls, aged 3 years 8 months to 
11 years 4 months, the average age of patients was 8 years 4 
months ± 2 years 8 months.
The study used a clinical method that included the collec-
tion of history data, physical examination with an assessment 
of growth and body weight, the overall health of the child at 
the beginning and at the end of the study, an assessment of the 
tolerability and organoleptic qualities of low-protein products 
according to the 5 points system, which was carried out using 
telephone and online contacts. All data obtained were recorded 
in an individual registration card.
Laboratory research methods included a biochemical (fluo-
rimetric) method for determining the level of phenylalanine in 
blood serum before prescribing the test products and against the 
background of their intake 1–2 days before the end of the study.
Statistical processing of the obtained data was carried out 
using the STATISTICA 13.0 package (StatSoftInc., USA). Median 
(Me) values as well as 5th and 95th percentiles were used to de-
scribe the test indicators. The differences between the two de-
pendent groups were assessed using a non-parametric Wilcoxon 
test. The probability of error (p) was considered statistically sig-
nificant at values < 0.01
3. Results and discussion
In the course of experimental studies, optimal ratios of 
starch and dry ingredients of chicken eggs were determined, 
which is very important for maintaining such a quota of protein, 
which at the output of the production cycle will be the permis-
sible concentration for a low-protein product. So, to prepare a 
mixture of starch: dry egg white, the content of the latter should 
be no more than 5%, for the mixture starch: melange — 10%, and 
starch: yolk — 15%.
With the addition of egg products and an increase in their 
quota, the content of amino acids and trace elements in the end 
product also increases compared to the starting starch, while the 
amount of phenylalanine varies slightly.
It should be noted that the moisture-thermal treatment of 
the starch protein mixture can be used to produce an artificial 
egg substitute as a separate semi-product. The food composition 
obtained by mechanical mixing of swellable starch and dry egg 
products can be used as an additive for enriching already exist-



















Figure 1. Study Design 
Under supervisionthere were 10 patients with phenylketonuria, of which 4 boys and 6 girls, aged 
3 years 8 months to 11 years 4 months, the average age of patients was 8 years 4 months ± 2 
years 8 months. 
The study used a clinical method that included the collection of history data, physical 
examination with an assessment of growth and body weight, the overall health of the child at the 
beginning and at the end of the study, an assessment of the tolerability and organoleptic qualities 
of low-protein products according to the 5 points system, which was carried out using telephone 
and online contacts. All data obtained were recorded in an individual registration card. 
Children with inherited amino acid metabolism disorders 
3 to 18 years old 
(classical phenylketonuria) 
n=10 
Visit № 1 (before receiving the products under investigation) 
Signing of informed consent 
Clinical examination, evaluation of anthropometric and physical data 
Taking Blood for Phenylalanine Test Form 
Product Issuance 
Telephone contact № 1 (week 2) 
-performance of appetite, attitude to food 
(for children under 6 years of age, a "eats" "does not eat" assessment, 
for children over 6 years old - according to the 5-point system) 
- state of skin (presence/absence of rash) 
- gastrointestinal state (frequency, stool character) 
Telephone Contact № 2 (Week 3) 
-performance of appetite, attitude to food 
-the state of the skin-gastrointestinal status 
Telephone contact № 3 (week 4) 
-performance of appetite, attitude to food 
-the state of the skin-gastrointestinal status 
Visit №2 (5th week against the background of obtaining investigated products) 
Clinical examination, evaluation of anthropometric and physical data 
Taking Blood for Phenylalanine Test Form 
Figure 1. Study Design
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baking bread and a filler in various bakery and vegetable dishes 
(tins, vegetable balls, cutlets, etc.).
In order to increase the nutritional value of low-protein pas-
ta (noodles, vermichel, “spider”) widely used in medicinal nutri-
tion of patients with PKU, dry egg products were introduced into 
their composition.
3.1. Product Assignment Procedure
After the initial examination and assessment of nutritive 
status (anthropometric indicators), each child was assigned all 
3 types of the studied products as part of the low-protein menu 
throughout the follow-up. The products were given home for 30 
days in the form of semi-finished products at the rate of 1 bag 
(1.0 kg) of each product for use as an independent dish (pasta, 
vermichel, noodles) or a component for the preparation of other 
dishes (soup, stew, casserole, etc.).
The investigated products were introduced into the diets of 
children with phenylketonuria in the form of ready-made dishes 
instead of previously used similar products of other manufac-
turers in accordance with clinical recommendations for provid-
ing medical care to children with PKU [9] and the fundamental 
principles of hypophenylalanine diet organization [10,11]. The 
duration of each product intake was 10 days, in order to avoid 
uniformity of diet, the products alternated throughout the study.
Organoleptic properties (taste, consistency), as well as the 
appearance of new low-protein mixtures of starch enriched 
“Vermichel,” “Noodles,” “Spider,” intended for dietary thera-
peutic nutrition for children over 3 years old, all children rated 
“good” and “excellent.” Most of them (7 out of 10 children) noted 
higher palatability compared to previous versions of these prod-
ucts. Three children noted the best appearance, consistency and 
taste of vermichel, the rest of the children did not single out any 
separate product. Results of assessment of organoleptic proper-
ties of low-protein products are given in Table 1.
Table 1
Assessment of organoleptic properties of dishes 






М ± m 4.9 ± 0.18 4.4 ± 0.41 4.8 ± 0.32
Min 4.0 4.0 4.0
Max 5.0 5.0 5.0
consistency
М ± m 4.5 ± 0.5 4.45 ± 0.45 4.45 ± 0.45
Min 4.0 4.0 4.0
Max 5.0 5.0 5.0
taste
М ± m 5.0 4.8 ± 0.32 4.9 ± 0.2
Min 5.0 4.0 4.0
Max 5.0 5.0 5.0
Physical development indicators before the study began in 
8 children corresponded to average age values, one child had 
mild malnutrition, and another child had excess body weight. 
Against the background of the intake of the studied products, 
body weight indicators tended to increase, but remained within 
the age norm in 8 children, in a child with overweight during the 
observation period, the increase was only 100 g, in a child with 
malnutrition, the body weight increased to the lower limit of the 
average age indicators.
The main criterion for the effectiveness of the hypophenyl-
alanine diet, which necessarily uses low-protein products, is the 
concentration of phenylalanine in the blood serum of patients. 
According to clinical recommendations, the therapeutic range of 
phenylalanine in the blood is 2–6 mg% for patients of all ages, 
however, for adolescents with PKU over 12 years old, it is allowed 
to increase to 10 mg% in the absence of neurological clinical 
symptoms. At the time of inclusion in the study, two of our pa-
tients had elevated levels of phenylalanine in the blood (7.1 mg% 
and 11.4mg%) due to periodic diet impairment, during the use of 
new low-protein products, phenylalanine in the blood decreased 
in these children, remaining only slightly elevated (6.8 mg%) in 
a teenager of 11.5 years due to increased control over compli-
ance with the diet. In all other children, the serum content of 
phenylalanine was not increased and remained in the range of 
2 to 6 mg%. The dynamics of the serum phenylalanine values 
before and at the end of the study are shown in Table 2.
Table 2
Dynamics of parameters of body weight, growth 
and content of phenylalanine in blood serum in children 
with classical phenylketonuria against the background 








At using the 
products under 
investigation




Phenylalanine in the 
bloodserum (mg%) 4.45 (2.4;12.5) 2.65 (2.0;8,7) 0.0001
* Wilcoxon criteria
4. Conclusion
Thus, the clinical testing of new pasta low-protein products 
“Vermichel,” “Noodles,” “Spider,” produced using modern tech-
nologies enriched with dry yolk and carotene (“Vetoron” — chil-
dren’s solution) showed high organoleptic qualities and effec-
tiveness in maintaining the stability of the permissible level of 
phenylalanine in the blood of children with phenylketonuria Use 
of the above products allows to expand the range of hypophenyl-
alanine diet and increase its nutritional value.
The positive results of the study indicate the possibility of 
widespread use of new enriched low-protein starch products in 
the practice of therapeutic nutrition in diseases requiring a low-
protein diet.
REFERENSES
1. Bykova, S.T., Buravlyova, T.N. (2011). Using the dry ingredients to egg 
dressing low-protein starch. Storage and processing of farm products, 10, 
70–72. (In Russian)
2. Bykova, S.T., Buravleva, T.N., Kalinina, T.E., Borovik, T. V. Food composi-
tion for the preparation of infant foods. Patent RF, no. 2462050, 2012. 
(In Russian)
3. Bykova, S.T., Kalinina, T.G. (2018). The use of dry egg products in the diet 
of children with phenylketonuria. Proceedings of the Scientific Conference 
“Topical issues of creating functional products of poultry and other branches 
of the food industry” Moscow Region: VNIIPP, 78–83. (In Russian)
4. Georgieva, O.V., Bykova, S.T., Kalinina, T.G., Varitsev, P. Yu. (2018). Use 
of specialised products manufactured in Russia for dietetic (therapeu-
tic) nutrition of infants with congenital disorders of protein metabolism. 
Pediatric Nutrition, 16(4), 73–79. https://doi.org/10.20953/1727–5784–
2018–4–73–79 (In Russian)
5. Bushueva, T.V., Borovik, T.E., Roslavtseva, E.A., Semenova, N.N. (2018). 
New possibilities of diet therapy for patients with phenylketonuria old-
er than one year. Collection of scientific papers “Molecular biological 
technologies in medical practice”. Akademizdat, Novosibirsk, 174–180. 
(In Russian)
23
ПИЩЕВЫЕ СИСТЕМЫ  |  Том 3 № 4  |  2020 FOOD SYSTEMS  |  Volume 3 № 4  |  2020
6. Bykova S.T., Kalinina  T.  G. (2019). Low-protein pasta for children pa-
tients with phenylketonuria. Food systems, 2(3), 20–22. https://doi.
org/10.21323/2618–9771–2019–2–3–20–22
7. Program for optimizing the nutrition of children aged 1 to 3 years in the 
Russian Federation. Methodological recommendations. (2019).Moscow: 
Scientific Center of Children’s Health. — 36 p. ISBN 978–5–6043946–0–1 
(In Russian)
8. Borovik, T.E., Ladodo, K.S., Bushueva, T.V., Timofeeva, A.G., Kon’, I. Ya., 
Kruglik, V.I., Volkova, I.N. (2013). Dietotherapy of Classical Phenylke-
tonuria: Criteria for Choosing Specialized Phenylalanine-Free Products. 
Current Pediatrics, 12(5), 40–48. (In Russian)
9. Phenylketonuria and tetrahydropterin metabolism disorders in chil-
dren. Clinical recommendations. [Electronic resource: https://www.
pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-
rekomendatsii/%D0%A4%D0%9A%D0%A3%20_%D0%BA%D0%BB%D0
%B8%D0%BD%D1%80%D0%B5%D0%BA%D0%B8_2017.pdf Access date 
15.08.2020] (In Russian)
10. Bushueva, T. V., Borovik, T. E., Fisenko, A. P., Baranov, A. A., Kuzen-
kova,  L.  M., Zvonkova, N. G., Timofeeva, A. G., Diakonova, E.  Yu., Sat-
tarova, V. V. (2018). Specialized medical nutrition products for children 
with phenylketonuria. Moscow: Scientific Center of Children’s Health. — 
128 p. ISBN978–5–9500392–8–7 (In Russian)
11. Borovik, T.E., Ladodo, K.S. (2015). Clinical dietetics of children. A guide 
for physicians. Moscow: MIA.-720 p. ISBN 978–5–9986–0225–2 (In Rus-
sian)
AUTНOR INFORMATION
Svetlana T. Bykova — candidate of technical sciences, Scientific Secretary, All-Russian Research Institute for Starch Products — Branch of V. M. Gorbatov Fed-
eral Research Center for Food Systems of RAS, 140051, Moscow region, Kraskovo, Nekrasov str., 11.Tel.:+7–495–557–23–85. E-mail: vniik@arrisp.ru
ORCID: https://orcid.org/0000–0002–6483–1319
*corresponding author
Tamara G. Kalinina — candidate of technical sciences, leading researcher, Department of biodegradable polymers, technological tests and experimental pro-
duction, All-Russian Research Institute for Starch Products — Branch of V. M. Gorbatov Federal Research Center for Food Systems of RAS, 140051, Moscow 
region, Kraskovo, Nekrasov str., 11. Tel.:+7–495–557–15–00. E-mail: vniik@arrisp.ru
ORCID: https://orcid.org/0000–0002–9751–6315
TatyanaV. Bushueva– doctor of medical sciences, leading researcher, Laboratory of nutrition of a healthy and sick child, Scientific Center of Children’s Health, 
119991, Moscow, Lomonosovavenue, 2, Build. 1.
Research Centre for Medical Genetics, 115522, Moscow, Moskvorechye str., 1
Tel.: +7–499–132–26–00. E-mail: tbushueva1@yandex.ru
ORCID: https://orcid.org/0000–0001–9893–9291
Tatyana E. Borovik — doctor of medical sciences, professor, Head of the laboratory of nutrition of a healthy and sick child, Scientific Center of Children’s Health, 
119991, Moscow, Lomonosov avenue, 2, Build. 1.
I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991, Moscow, Trubetskaya str. 8–2.
Tel.: +7–499–132–26–00. E-mail: nutrborovik@mail.ru
ORCID: https://orcid.org/0000–0002–0603–3394
All authors bear responsibility for the work and presented data.
All authors made an equal contribution to the work.
The authors were equally involved in writing the manuscript and bear the equal responsibility for plagiarism.
The authors declare no conflict of interest.
Received 28.08.2020 Accepted in revised 01.12.2020 Accepted for publication 22.12.2020
